1. Home
  2. HOVR vs CALC Comparison

HOVR vs CALC Comparison

Compare HOVR & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Horizon Aircraft Ltd.

HOVR

New Horizon Aircraft Ltd.

HOLD

Current Price

$2.09

Market Cap

103.1M

Sector

Finance

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$5.50

Market Cap

88.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOVR
CALC
Founded
2013
2011
Country
Canada
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.1M
88.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HOVR
CALC
Price
$2.09
$5.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$6.50
$16.00
AVG Volume (30 Days)
986.8K
104.9K
Earning Date
01-14-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$1.42
52 Week High
$4.18
$7.20

Technical Indicators

Market Signals
Indicator
HOVR
CALC
Relative Strength Index (RSI) 57.32 51.32
Support Level $1.96 $5.12
Resistance Level $2.39 $6.18
Average True Range (ATR) 0.21 0.77
MACD 0.06 -0.15
Stochastic Oscillator 63.94 18.27

Price Performance

Historical Comparison
HOVR
CALC

About HOVR New Horizon Aircraft Ltd.

New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: